Title : Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling.

Pub. Date : 2020 Oct

PMID : 32935463






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling. Melatonin AKT serine/threonine kinase 1 Homo sapiens
2 Molecular mechanistic studies further uncovered that melatonin synergized with dabrafenib to inhibit AKT and EMT signalling pathways. Melatonin AKT serine/threonine kinase 1 Homo sapiens